NEWS

DSI’s recent acquisition by Paris-based Product Life Group (PLG) has granted the company options to further expand into the European market. We hold prior experience in Europe and ROW and are excited to explore more opportunities in these regions. The addition of PLG’s resources and support will allow the DS […]

Join the DSI team in Boston on September 28-29, 2022 at Biopharm America! We’re excited to be back in-person at BPA this year. For 2022, the conference is also providing two virtual days, October 4-5, 2022, for those unable to attend the conference in-person. We will be participating in the […]

DSI announced today that it will be actively engaged in partnering meetings during the BIO International Convention. The 2022 BIO International Convention will transition to a virtual and in-person (optional) event format. This virtual gathering of the global biotech industry provides access to partners via BIO One-on-One Partnering and educational […]

DSI plans to attend the 2022 BIO Europe Spring conference virtually. Our new Director of Business Development, Ben Luts, will be joining the conference on behalf of DSI. To set up a meeting with Ben, contact him at bluts@dsinpharmatics.com or through the partnering site. Whether you’ve used our services in […]

DESIGN SPACE INPHARMATICS (DSI) ANNOUNCES APPOINTMENT OF BEN LUTS AS DIRECTOR OF BUSINESS DEVELOPMENT (Harleysville, PA; February 1, 2022) – Design Space InPharmatics (DSI), a full-service CMC consulting firm focused on providing pharmaceutical attributes, regulatory affairs, and drug discovery and development consulting services, is delighted to announce today the appointment […]

Each year, healthcare, pharmaceutical, and biotechnology executives attend the JP Morgan Healthcare Conference, some to tout recent developments, others just to bounce from session to session. We work hard at DSI to make life science companies better at what you do in the Chemistry, Manufacturing and Controls (CMC) areas. We’ve […]